Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents.
Davidson
M H
MH
Chicago Center for Clinical Research, Department of Preventive Cardiology, Rush-Presbyterian--St Luke's Medical Center, Illinois 60610-4324, USA.
D001161:Arteriosclerosis / Q000097:blood* / Q000188:drug therapy; D015415:Biomarkers / Q000097:blood; D003226:Congresses as Topic; D004341:Drug Evaluation / Q000379:methods; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008075:Lipoproteins, HDL / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood*; D013548:Sweden
D015415:Biomarkers; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL